Defence Therapeutics Inc
XBER:DTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Defence Therapeutics Inc
XBER:DTC
|
CA |
|
M
|
Mount Gibson Iron Ltd
F:FWQ
|
AU |
|
F
|
Fort St James Nickel Corp
XTSX:FTJ
|
CA |
|
DMW Corp
TSE:6365
|
JP |
|
D
|
Dometic Group AB (publ)
F:D00
|
SE |
|
F
|
Fill Up Media SA
F:X3D
|
FR |
|
Fintech Select Ltd
XTSX:FTEC
|
CA |
|
Neoen SA
OTC:NOSPF
|
FR |
|
G
|
Guerbet SA
XBER:4G8
|
FR |
|
Idemitsu Kosan Co Ltd
F:I7B
|
JP |
|
D
|
District Mines Ltd
XTSX:DIG.H
|
CA |
|
R
|
RDARS Inc
CNSX:RDRS
|
CA |
|
Alumina Ltd
ASX:AWC
|
AU |
|
Healixa Inc
OTC:EMOR
|
US |
|
C
|
Comsys Holdings Corp
XBER:CS7
|
JP |
|
Drone Guarder Inc
OTC:DRNG
|
UK |
|
Techstep ASA
F:B1T0
|
NO |
|
A
|
Acceleware Ltd
OTC:ACWRF
|
CA |
|
Elecom Co Ltd
OTC:ELCMF
|
JP |
Bankruptcy Probability
Defence Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Defence Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
D
|
Defence Therapeutics Inc
CNSX:DTC
|
29.2m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
457.3B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
45B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
35.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
26.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
25.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
25.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Defence Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Defence Therapeutics Inc has total debt of 1.6m CAD. This includes both short-term (0 CAD) and long-term (1.6m CAD) debt.
You can find a full breakdown on its Balance Sheet.
